Exact Mass: 1058.5436554

Exact Mass Matches: 1058.5436554

Found 111 metabolites which its exact mass value is equals to given mass value 1058.5436554, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

   

Hemsloside Ma 2

6-{[4,4,6a,6b,11,11,14b-heptamethyl-8a-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl]oxy}-3-hydroxy-4,5-bis[(3,4,5-trihydroxyoxan-2-yl)oxy]oxane-2-carboxylic acid

C52H82O22 (1058.5297472)


Momordin IId is found in green vegetables. Momordin IId is a constituent of Chinese cucumber (Momordica cochinchinensis). Constituent of Chinese cucumber (Momordica cochinchinensis). Hemsloside Ma 2 is found in green vegetables.

   

Matesaponin 2

3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl 10-[(5-hydroxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl)oxy]-1,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid

C53H86O21 (1058.5661306)


Matesaponin 2 is found in beverages. Matesaponin 2 is a constituent of mat leaf (Ilex paraguariensis). Constituent of maté leaf (Ilex paraguariensis). Matesaponin 2 is found in tea and beverages.

   

Helianthoside A

10-{[4-({3,4-dihydroxy-6-methyl-5-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-3,5-dihydroxy-6-{[(3,4,5-trihydroxyoxan-2-yl)oxy]methyl}oxan-2-yl]oxy}-5-hydroxy-2,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylic acid

C53H86O21 (1058.5661306)


Helianthoside A is found in fats and oils. Helianthoside A is a constituent of Helianthus annuum (sunflower). Constituent of Helianthus annuum (sunflower). Helianthoside A is found in sunflower and fats and oils.

   

Araloside B

6-{[4,4,6a,6b,11,11,14b-heptamethyl-8a-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl]oxy}-3,4-bis({[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy})-5-hydroxyoxane-2-carboxylic acid

C52H82O22 (1058.5297472)


Araloside B is found in green vegetables. Araloside B is from Aralia elata (Japanese angelica tree From Aralia elata (Japanese angelica tree). Araloside B is found in green vegetables.

   

Kinetensin 1-8

(2S)-2-{[(2S)-2-({[(2S)-1-[(2S)-2-{[(2S)-2-{[(2S)-2-{[(2S)-2-{[(2S,3S)-2-amino-1-hydroxy-3-methylpentylidene]amino}-1-hydroxypropylidene]amino}-5-carbamimidamido-1-hydroxypentylidene]amino}-5-carbamimidamido-1-hydroxypentylidene]amino}-3-(1H-imidazol-5-yl)propanoyl]pyrrolidin-2-yl](hydroxy)methylidene}amino)-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-3-phenylpropanoate

C50H74N16O10 (1058.5773543999999)


Kinetensin 1-8 is a fraction of kinetensin with only an Ile-Ala-Arg-Arg-His-Pro-Tyr-Phe peptide chain. Kinetensin is a nonapeptide, originally isolated from pepsin-treated plasma that shares some sequence homology with the C-terminal end of neurotensin, serum albumin, and angiotensin. It is a potent histamine releaser in rodents and may serve as an inflammatory mediator. Kinetensin 1-8 is a fraction of Kinetensin with only Ile-Ala-Arg-Arg-His-Pro-Tyr-Phe peptide chain.

   

PIP(20:1(11Z)/6 keto-PGF1alpha)

{[(1S,6R,15S,16S,18R,19S,20R,21R,22R,23S,24R)-3,16,18,20,22,23,24-heptahydroxy-19-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-6-{[(11Z)-icos-11-enoyloxy]methyl}-3,8,13-trioxo-2,4,7-trioxa-3lambda5-phosphabicyclo[13.6.3]tetracosan-21-yl]oxy}phosphonic acid

C49H88O20P2 (1058.5343908)


PIP(20:1(11Z)/6 keto-PGF1alpha) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(20:1(11Z)/6 keto-PGF1alpha), in particular, consists of one chain of 11Z-eicosenoyl at the C-1 position and one chain of 6-Keto-prostaglandin F1alpha at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(6 keto-PGF1alpha/20:1(11Z))

{[(1S,6R,16S,17S,19R,20S,21R,22R,23R,24S,25R)-3,17,19,21,23,24,25-heptahydroxy-20-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-6-[(11Z)-icos-11-enoyloxy]-3,9,14-trioxo-2,4,8-trioxa-3lambda5-phosphabicyclo[14.6.3]pentacosan-22-yl]oxy}phosphonic acid

C49H88O20P2 (1058.5343908)


PIP(6 keto-PGF1alpha/20:1(11Z)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(6 keto-PGF1alpha/20:1(11Z)), in particular, consists of one chain of 6-Keto-prostaglandin F1alpha at the C-1 position and one chain of 11Z-eicosenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(20:1(11Z)/TXB2)

{[(1S,6R,12Z,15S,16S,20R,21R,22R,23R,24S,25R)-3,16,18,21,23,24,25-heptahydroxy-20-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-6-{[(11Z)-icos-11-enoyloxy]methyl}-3,8-dioxo-2,4,7,19-tetraoxa-3lambda5-phosphabicyclo[13.7.3]pentacos-12-en-22-yl]oxy}phosphonic acid

C49H88O20P2 (1058.5343908)


PIP(20:1(11Z)/TXB2) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(20:1(11Z)/TXB2), in particular, consists of one chain of 11Z-eicosenoyl at the C-1 position and one chain of Thromboxane B2 at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(TXB2/20:1(11Z))

{[(1S,6R,13Z,16S,17S,21R,22R,23R,24R,25S,26R)-3,17,19,22,24,25,26-heptahydroxy-21-[(1E,3S)-3-hydroxyoct-1-en-1-yl]-6-[(11Z)-icos-11-enoyloxy]-3,9-dioxo-2,4,8,20-tetraoxa-3lambda5-phosphabicyclo[14.7.3]hexacos-13-en-23-yl]oxy}phosphonic acid

C49H88O20P2 (1058.5343908)


PIP(TXB2/20:1(11Z)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(TXB2/20:1(11Z)), in particular, consists of one chain of Thromboxane B2 at the C-1 position and one chain of 11Z-eicosenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(22:2(13Z,16Z)/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

{[(1R,3S)-3-({[(2R)-3-[(13Z,16Z)-docosa-13,16-dienoyloxy]-2-{[(5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoyl]oxy}propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C53H88O17P2 (1058.5496458)


PIP(22:2(13Z,16Z)/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(22:2(13Z,16Z)/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)), in particular, consists of one chain of 13Z,16Z-docosadienoyl at the C-1 position and one chain of 4-hydroxy-docosahexaenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/22:2(13Z,16Z))

{[(1R,3S)-3-({[(2R)-2-[(13Z,16Z)-docosa-13,16-dienoyloxy]-3-{[(5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoyl]oxy}propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C53H88O17P2 (1058.5496458)


PIP(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/22:2(13Z,16Z)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/22:2(13Z,16Z)), in particular, consists of one chain of 4-hydroxy-docosahexaenoyl at the C-1 position and one chain of 13Z,16Z-docosadienoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(22:2(13Z,16Z)/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

{[(1R,3S)-3-({[(2R)-3-[(13Z,16Z)-docosa-13,16-dienoyloxy]-2-{[(4Z,8Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoyl]oxy}propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C53H88O17P2 (1058.5496458)


PIP(22:2(13Z,16Z)/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(22:2(13Z,16Z)/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)), in particular, consists of one chain of 13Z,16Z-docosadienoyl at the C-1 position and one chain of 7-hydroxy-docosahexaenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/22:2(13Z,16Z))

{[(1R,3S)-3-({[(2R)-2-[(13Z,16Z)-docosa-13,16-dienoyloxy]-3-{[(4Z,8Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoyl]oxy}propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C53H88O17P2 (1058.5496458)


PIP(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/22:2(13Z,16Z)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/22:2(13Z,16Z)), in particular, consists of one chain of 7-hydroxy-docosahexaenoyl at the C-1 position and one chain of 13Z,16Z-docosadienoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

{[(1R,3S)-3-({[(2R)-3-[(13Z,16Z)-docosa-13,16-dienoyloxy]-2-{[(4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoyl]oxy}propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C53H88O17P2 (1058.5496458)


PIP(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)), in particular, consists of one chain of 13Z,16Z-docosadienoyl at the C-1 position and one chain of 14-hydroxy-docosahexaenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/22:2(13Z,16Z))

{[(1R,3S)-3-({[(2R)-2-[(13Z,16Z)-docosa-13,16-dienoyloxy]-3-{[(4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoyl]oxy}propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C53H88O17P2 (1058.5496458)


PIP(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/22:2(13Z,16Z)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/22:2(13Z,16Z)), in particular, consists of one chain of 14-hydroxy-docosahexaenoyl at the C-1 position and one chain of 13Z,16Z-docosadienoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

{[(1R,3S)-3-({[(2R)-3-[(13Z,16Z)-docosa-13,16-dienoyloxy]-2-{[(4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoyl]oxy}propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C53H88O17P2 (1058.5496458)


PIP(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)), in particular, consists of one chain of 13Z,16Z-docosadienoyl at the C-1 position and one chain of 17-hydroxy-docosahexaenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/22:2(13Z,16Z))

{[(1R,3S)-3-({[(2R)-2-[(13Z,16Z)-docosa-13,16-dienoyloxy]-3-{[(4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoyl]oxy}propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C53H88O17P2 (1058.5496458)


PIP(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/22:2(13Z,16Z)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/22:2(13Z,16Z)), in particular, consists of one chain of 17-hydroxy-docosahexaenoyl at the C-1 position and one chain of 13Z,16Z-docosadienoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

{[(1R,3S)-3-({[(2R)-3-[(13Z,16Z)-docosa-13,16-dienoyloxy]-2-{[(4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoyl]oxy}propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C53H88O17P2 (1058.5496458)


PIP(22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)), in particular, consists of one chain of 13Z,16Z-docosadienoyl at the C-1 position and one chain of 16,17-epoxy-docosapentaenoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   

PIP(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/22:2(13Z,16Z))

{[(1R,3S)-3-({[(2R)-2-[(13Z,16Z)-docosa-13,16-dienoyloxy]-3-{[(4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoyl]oxy}propoxy](hydroxy)phosphoryl}oxy)-2,4,5,6-tetrahydroxycyclohexyl]oxy}phosphonic acid

C53H88O17P2 (1058.5496458)


PIP(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/22:2(13Z,16Z)) is an oxidized phosphatidylinositol phosphate (PIP). As other PIPs, oxidized phosphatidylinositol phosphates are acidic (anionic) phospholipids that consist of a phosphatidic acid backbone, linked via the phosphate group to a phosphorylated inositol (hexahydroxycyclohexane). Phosphatidylinositol phosphates are generated from phosphatidylinositols, which are phosphorylated by a number of different kinases that place the phosphate moiety on positions 4 and 5 of the inositol ring, although position 3 can also be phosphorylated. Phosphatidylinositol phosphates can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. PIP(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/22:2(13Z,16Z)), in particular, consists of one chain of 16,17-epoxy-docosapentaenoyl at the C-1 position and one chain of 13Z,16Z-docosadienoyl at the C-2 position. The most important phosphatidylinositol phosphate in both quantitative and biological terms is phosphatidylinositol 4-phosphate. Phosphatidylinositol and the phosphatidylinositol phosphates are the main source of diacylglycerols that serve as signaling molecules, via the action of phospholipase C enzymes. Phosphatidylinositol phosphates are usually present at low levels only in tissues, typically at about 1 to 3\\% of the concentration of phosphatidylinositol.

   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

Soyasapogenol B base + O-HexA-dHex-dHex-Pen

Soyasapogenol B base + O-HexA-dHex-dHex-Pen

C53H86O21 (1058.5661306)


Annotation level-3

   

3-O-alpha-L-arabinopyranosyl-ursolic acid 28-O-alpha-L-rhamnopyranosyl-(1->4)-beta-D-gentiobiosyl ester|ursolic acid alpha-L-arabinopyranosyl-28-O-alpha-L-rhamnopyranosyl-(1->4)-O-beta-gentiobiosyl ester|ursolic acid-3-O-alpha-L-arabinopyranosyl-28-O-alpha-L-rhamnopyranosyl-(1->4)-O-beta-D-glucopyranosyl-(1-6)-O-beta-D-glucopyranoside

3-O-alpha-L-arabinopyranosyl-ursolic acid 28-O-alpha-L-rhamnopyranosyl-(1->4)-beta-D-gentiobiosyl ester|ursolic acid alpha-L-arabinopyranosyl-28-O-alpha-L-rhamnopyranosyl-(1->4)-O-beta-gentiobiosyl ester|ursolic acid-3-O-alpha-L-arabinopyranosyl-28-O-alpha-L-rhamnopyranosyl-(1->4)-O-beta-D-glucopyranosyl-(1-6)-O-beta-D-glucopyranoside

C53H86O21 (1058.5661306)


   

3beta-O-(beta-D-xylopyranosyl)-olean-12-ene-28-O-(alpha-L-rhamnopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->4)-beta-D-glucopyranosyl) ester

3beta-O-(beta-D-xylopyranosyl)-olean-12-ene-28-O-(alpha-L-rhamnopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->4)-beta-D-glucopyranosyl) ester

C53H86O21 (1058.5661306)


   

3-O-{beta-D-apiofuranosyl-(1->4)-[alpha-L-arabinopyranosyl-(1->2)]-beta-D-glucuronopyranosyl}oleanolic acid 28-O-beta-D-glucopyranosyl ester

3-O-{beta-D-apiofuranosyl-(1->4)-[alpha-L-arabinopyranosyl-(1->2)]-beta-D-glucuronopyranosyl}oleanolic acid 28-O-beta-D-glucopyranosyl ester

C52H82O22 (1058.5297472)


   
   
   

3-O-{[beta-D-galactopyranosyl(1->2)]-alpha-L-rhamnopyranosyl(1->4)-beta-D-glucuronopyranosyl}-28-O-isovaleroylbarringtogenol C

3-O-{[beta-D-galactopyranosyl(1->2)]-alpha-L-rhamnopyranosyl(1->4)-beta-D-glucuronopyranosyl}-28-O-isovaleroylbarringtogenol C

C53H86O21 (1058.5661306)


   

3-O-alpha-L-arabinopyranosyl-30-norhederagenin 28-O-alpha-L-rhamnopyranosyl(1-4)-beta-D-glucopyranosyl-(1-6)-beta-D-glucopyranoside|sinofoside A

3-O-alpha-L-arabinopyranosyl-30-norhederagenin 28-O-alpha-L-rhamnopyranosyl(1-4)-beta-D-glucopyranosyl-(1-6)-beta-D-glucopyranoside|sinofoside A

C52H82O22 (1058.5297472)


   

3-O-beta-D-glucopyranosyl-oleanolic acid-28-O-beta-D-glucopyranosyl-(1->4)-[alpha-L-rhamnopyranosyl-(1->2)]-beta-D-xylopyranoside

3-O-beta-D-glucopyranosyl-oleanolic acid-28-O-beta-D-glucopyranosyl-(1->4)-[alpha-L-rhamnopyranosyl-(1->2)]-beta-D-xylopyranoside

C53H86O21 (1058.5661306)


   
   

3-O-alpha-L-rhamnopyranosyl(1-2)-alpha-L-arabinopyranosyloleanolic acid 28-O-beta-D-glucopyranosyl(1-6)-beta-D-glucopyranoside

3-O-alpha-L-rhamnopyranosyl(1-2)-alpha-L-arabinopyranosyloleanolic acid 28-O-beta-D-glucopyranosyl(1-6)-beta-D-glucopyranoside

C53H86O21 (1058.5661306)


   

21beta-angeloyloxy-3beta-[beta-D-glucopyranosyl-(1->2)]-[beta-D-xylopyranosyl-(1->3)]-beta-D-glucuronopyranosyloxyolean-12-ene-15alpha,16alpha,22alpha,28-tetrol|eryngioside 94A

21beta-angeloyloxy-3beta-[beta-D-glucopyranosyl-(1->2)]-[beta-D-xylopyranosyl-(1->3)]-beta-D-glucuronopyranosyloxyolean-12-ene-15alpha,16alpha,22alpha,28-tetrol|eryngioside 94A

C52H82O22 (1058.5297472)


   

coumoside A|coumoside B

coumoside A|coumoside B

C52H82O22 (1058.5297472)


   

3??-D-O-(??-L-Rhamnopyranosyl-(1鈥樏傗垎2)-??-L-arabinopyranosyl)-olean-12-ene-28-O-(??-D-glucopyranosyl-(1鈥樏傗垎4)-??-D-glucopyranosyl) ester

3??-D-O-(??-L-Rhamnopyranosyl-(1鈥樏傗垎2)-??-L-arabinopyranosyl)-olean-12-ene-28-O-(??-D-glucopyranosyl-(1鈥樏傗垎4)-??-D-glucopyranosyl) ester

C53H86O21 (1058.5661306)


   
   
   

3beta-O-[beta-D-xylopyranosyl(1->2)-alpha-L-arabinopyranosyl]olean-12-en-27-al-28-oic acid 28-O-[beta-D-glucopyranosyl(1->6)-beta-D-glucopyranosyl] ester

3beta-O-[beta-D-xylopyranosyl(1->2)-alpha-L-arabinopyranosyl]olean-12-en-27-al-28-oic acid 28-O-[beta-D-glucopyranosyl(1->6)-beta-D-glucopyranosyl] ester

C52H82O22 (1058.5297472)


   

3-O-beta-D-xylopyranosyl-(1->2)-alpha-L-arabinopyranosyl-28-O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl gypsogenin

3-O-beta-D-xylopyranosyl-(1->2)-alpha-L-arabinopyranosyl-28-O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl gypsogenin

C52H82O22 (1058.5297472)


   
   

[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl] 10-[3,4-dihydroxy-6-methyl-5-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy-2,2,6b,9,9,12a-hexamethyl-3,4,5,6,6a,7,8,8a,10,11,12,13,14,14b-tetradecahydro-1H-picene-4a-carboxylate

[3,4,5-trihydroxy-6-[[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl] 10-[3,4-dihydroxy-6-methyl-5-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxy-2,2,6b,9,9,12a-hexamethyl-3,4,5,6,6a,7,8,8a,10,11,12,13,14,14b-tetradecahydro-1H-picene-4a-carboxylate

C53H86O21 (1058.5661306)


   
   
   

3beta-[(beta-D-glucopyranosyl)oxy]-olean-12-en-28-oic acid O-alpha-L-rhamnopyranosyl-(1?2)-[beta-D-xylopyranosyl-(1?6)]-beta-D-glucopyranosyl ester|loniceroside E

3beta-[(beta-D-glucopyranosyl)oxy]-olean-12-en-28-oic acid O-alpha-L-rhamnopyranosyl-(1?2)-[beta-D-xylopyranosyl-(1?6)]-beta-D-glucopyranosyl ester|loniceroside E

C53H86O21 (1058.5661306)


   

3-O-[alpha-L-rhamnopyranosyl-(1?3)-beta-D-glucopyranosyl-(1?3)-alpha-L-rhamnopyranosyl-(1?2)-alpha-L-arabinopyranosyl]hederagenin

3-O-[alpha-L-rhamnopyranosyl-(1?3)-beta-D-glucopyranosyl-(1?3)-alpha-L-rhamnopyranosyl-(1?2)-alpha-L-arabinopyranosyl]hederagenin

C53H86O21 (1058.5661306)


   

3-O-?-D-glucopyranosyl(1?4)-?-D-glucopyranosyl(1?3)-alpha-L-rhamnopyranosyl(1?2)-alpha-L-arabinopyranosyloleanolic acid|3-O-beta-D-glucopyranosyl(1?4)-beta-D-glucopyranosyl (1?3)-alpha-L-rhamnopyranosyl (1?2) [beta-D-glucopyranosyl-(1?4)]-alpha-L-arabinopyranosyl oleanolic acid|3-O-[beta-D-glucopyranosyl(1?4)-beta-D-glucopyranosyl(1?3)-alpha-L-rhamnopyranosyl(1?2)-alpha-L-arabinopyranosyl]oleanolic acid|benzyl 3-O-[beta-D-glucopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->3)-alpha-L-rhamnopyranosyl-(1->2)-alpha-L-arabinopyranosyl]oleanolic acid|oleanolic acid 3-O-beta-D-glucopyranosyl-(1?4)-beta-D-glucopyranosyl-(1?3)-alpha-L-rhamnopyranosyl-(1?2)-alpha-L-arabinopyranoside

3-O-?-D-glucopyranosyl(1?4)-?-D-glucopyranosyl(1?3)-alpha-L-rhamnopyranosyl(1?2)-alpha-L-arabinopyranosyloleanolic acid|3-O-beta-D-glucopyranosyl(1?4)-beta-D-glucopyranosyl (1?3)-alpha-L-rhamnopyranosyl (1?2) [beta-D-glucopyranosyl-(1?4)]-alpha-L-arabinopyranosyl oleanolic acid|3-O-[beta-D-glucopyranosyl(1?4)-beta-D-glucopyranosyl(1?3)-alpha-L-rhamnopyranosyl(1?2)-alpha-L-arabinopyranosyl]oleanolic acid|benzyl 3-O-[beta-D-glucopyranosyl-(1->4)-beta-D-glucopyranosyl-(1->3)-alpha-L-rhamnopyranosyl-(1->2)-alpha-L-arabinopyranosyl]oleanolic acid|oleanolic acid 3-O-beta-D-glucopyranosyl-(1?4)-beta-D-glucopyranosyl-(1?3)-alpha-L-rhamnopyranosyl-(1?2)-alpha-L-arabinopyranoside

C53H86O21 (1058.5661306)


   

2alpha,3beta-dihydroxy-30-norolean-12,20(29)-dien-28-oic acid O-beta-D-xylopyranosyl-(1?3)-O-alpha-L-rhamnopyranosyl-(1?4)-O-beta-D-glucopyranosyl-(1?6)-beta-D-glucopyranosyl ester|akemisaponin I

2alpha,3beta-dihydroxy-30-norolean-12,20(29)-dien-28-oic acid O-beta-D-xylopyranosyl-(1?3)-O-alpha-L-rhamnopyranosyl-(1?4)-O-beta-D-glucopyranosyl-(1?6)-beta-D-glucopyranosyl ester|akemisaponin I

C52H82O22 (1058.5297472)


   
   
   

3-O-?-D-glucopyranosyl-(1?4)-O-alpha-L-rhamnopyranosyl-(1?2)-[O-?-D-glucopyranosyl-(1?4)]-O-alpha-L-arabinopyranosyloleanolic acid|3-O-beta-D-glucopyranosyl (1?3)-alpha-L-rhamnopyranosyl (1?2) [beta-D-glucopyranosyl (1?4)]-alpha-L-arabinopyranosyl oleanolic acid|3-O-[beta-D-glucopyranosyl-(1?3)-O-alpha-L-rhamnopyranosyl-(1?2)-[O-beta-D-glucopyranosyl-(1?4)]-O-alpha-L-arabinopyranosyl]oleanolic acid|oleanolic acid 3-O-beta-D-glucopyranosyl-(1?3)-alpha-L-rhamnopyranosyl-(1?2)-[beta-D-glucopyranosyl-(1?4)]-alpha-L-arabinopyranoside

3-O-?-D-glucopyranosyl-(1?4)-O-alpha-L-rhamnopyranosyl-(1?2)-[O-?-D-glucopyranosyl-(1?4)]-O-alpha-L-arabinopyranosyloleanolic acid|3-O-beta-D-glucopyranosyl (1?3)-alpha-L-rhamnopyranosyl (1?2) [beta-D-glucopyranosyl (1?4)]-alpha-L-arabinopyranosyl oleanolic acid|3-O-[beta-D-glucopyranosyl-(1?3)-O-alpha-L-rhamnopyranosyl-(1?2)-[O-beta-D-glucopyranosyl-(1?4)]-O-alpha-L-arabinopyranosyl]oleanolic acid|oleanolic acid 3-O-beta-D-glucopyranosyl-(1?3)-alpha-L-rhamnopyranosyl-(1?2)-[beta-D-glucopyranosyl-(1?4)]-alpha-L-arabinopyranoside

C53H86O21 (1058.5661306)


   

2alpha,3beta-dihydroxy-30-norolean-12,20(21)-dien-28-oic acid O-beta-D-xylopyranosyl-(1?3)-O-alpha-L-rhamnopyranosyl-(1?4)-O-beta-D-glucopyranosyl-(1?6)-beta-D-glucopyranosyl ester|akemisaponin B

2alpha,3beta-dihydroxy-30-norolean-12,20(21)-dien-28-oic acid O-beta-D-xylopyranosyl-(1?3)-O-alpha-L-rhamnopyranosyl-(1?4)-O-beta-D-glucopyranosyl-(1?6)-beta-D-glucopyranosyl ester|akemisaponin B

C52H82O22 (1058.5297472)


   
   

2alpha,3beta-dihydroxyurs-12,20(30)-dien-28-oic acid 3-O-{O-beta-D-glucopyranosyl-(1->2)-O-alpha-L-arabinopyranosyl-(1->2)-O-[beta-D-xylopyranosyl-(1->3)]beta-D-glucopyranoside}

2alpha,3beta-dihydroxyurs-12,20(30)-dien-28-oic acid 3-O-{O-beta-D-glucopyranosyl-(1->2)-O-alpha-L-arabinopyranosyl-(1->2)-O-[beta-D-xylopyranosyl-(1->3)]beta-D-glucopyranoside}

C52H82O22 (1058.5297472)


   

3?-[(O-alpha-L-rhamnopyranosyl-(1?2)-O-alpha-L-arabinopyranosyl)oxy]lup-20(29)-en-28-oic acid 28-O-?-d-glucopyranosyl-(1?6)-O-?-d-glucopyranosyl ester|3beta-[(O-alpha-L-rhamno-pyranosyl-(1?2)-alpha-L-arabinopyranosyl)oxy]-lup-20(29)-en-28-oic acid 28-O-beta-D-glucopyranosyl-(1?6)-beta-D-glucopyranosyl ester|3beta-[(O-alpha-L-rhamnopyranosyl-(1->2)-alpha-L-arabinopyranosyl)oxy]lup-20(29)-en-28-oic acid 28-O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl ester

3?-[(O-alpha-L-rhamnopyranosyl-(1?2)-O-alpha-L-arabinopyranosyl)oxy]lup-20(29)-en-28-oic acid 28-O-?-d-glucopyranosyl-(1?6)-O-?-d-glucopyranosyl ester|3beta-[(O-alpha-L-rhamno-pyranosyl-(1?2)-alpha-L-arabinopyranosyl)oxy]-lup-20(29)-en-28-oic acid 28-O-beta-D-glucopyranosyl-(1?6)-beta-D-glucopyranosyl ester|3beta-[(O-alpha-L-rhamnopyranosyl-(1->2)-alpha-L-arabinopyranosyl)oxy]lup-20(29)-en-28-oic acid 28-O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl ester

C53H86O21 (1058.5661306)


   

3-O-{[beta-D-xylopyranosyl-(1->2)]-[beta-D-xylopyranosyl-(1->4)]-beta-D-glucuronopyranosyl}-28-O-[beta-D-glucopyranosyl]oleanolic acid|3beta-{([O-beta-D-xylopyranosyl-(1->2)-O-beta-D-xylopyranosyl-(1->4)]-O-beta-D-glucopyranuronosyl)oxy}olean-12-en-28-oic acid 28-O-beta-D-glucopyranosyl ester|copteroside E

3-O-{[beta-D-xylopyranosyl-(1->2)]-[beta-D-xylopyranosyl-(1->4)]-beta-D-glucuronopyranosyl}-28-O-[beta-D-glucopyranosyl]oleanolic acid|3beta-{([O-beta-D-xylopyranosyl-(1->2)-O-beta-D-xylopyranosyl-(1->4)]-O-beta-D-glucopyranuronosyl)oxy}olean-12-en-28-oic acid 28-O-beta-D-glucopyranosyl ester|copteroside E

C52H82O22 (1058.5297472)


   

3-O-[alpha-L-rhamnopyranosyl-(1->2)-alpha-L-arabinopyranosyl]-3beta,23-dihydroxyolean-12-en-28-oic acid 28-O-[alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranosyl] ester|alpha-hederin 28-O-[alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranosyl] ester

3-O-[alpha-L-rhamnopyranosyl-(1->2)-alpha-L-arabinopyranosyl]-3beta,23-dihydroxyolean-12-en-28-oic acid 28-O-[alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranosyl] ester|alpha-hederin 28-O-[alpha-L-rhamnopyranosyl-(1->2)-beta-D-glucopyranosyl] ester

C53H86O21 (1058.5661306)


   

26-O-beta-D-glucopyranosyl-22-O-methyl-(25R)-furost-5-ene-1beta,3beta,22,26-tetrol 1-O-[O-alpha-L-rhamnopyranosyl-(1->2)-3,4,6-tri-O-acetyl-beta-D-galactopyranoside]

26-O-beta-D-glucopyranosyl-22-O-methyl-(25R)-furost-5-ene-1beta,3beta,22,26-tetrol 1-O-[O-alpha-L-rhamnopyranosyl-(1->2)-3,4,6-tri-O-acetyl-beta-D-galactopyranoside]

C52H82O22 (1058.5297472)


   

(3beta,20beta)-13,28-epoxy-16-oxo-3-{{O-beta-D-xylopyranosyl-(1-?2)-O-beta-D-glucopyranosyl-(1-?4)-O-[beta-D-glucopyranosyl-(1-?2)]-alpha-L-arabinopyranosyl}oxy}oleanan-29-al|3-O-{beta-D-xylopyranosyl-(1->2)-beta-D-glucopyranosyl-(1->4)-[beta-D-glucopyranosyl-(1->2)]-alpha-L-arabinopyranosyl}-3beta-hydroxy-13beta,28-epoxy-16-oxooleanan-30-al

(3beta,20beta)-13,28-epoxy-16-oxo-3-{{O-beta-D-xylopyranosyl-(1-?2)-O-beta-D-glucopyranosyl-(1-?4)-O-[beta-D-glucopyranosyl-(1-?2)]-alpha-L-arabinopyranosyl}oxy}oleanan-29-al|3-O-{beta-D-xylopyranosyl-(1->2)-beta-D-glucopyranosyl-(1->4)-[beta-D-glucopyranosyl-(1->2)]-alpha-L-arabinopyranosyl}-3beta-hydroxy-13beta,28-epoxy-16-oxooleanan-30-al

C52H82O22 (1058.5297472)


   
   

3beta-[(alpha-L-arabinopyranosyl)oxy]-23-hydroxylup-20(29)-en-28-oic acid 28-O-alpha-L-rhamnopyranosyl-(1->4)-O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl ester

3beta-[(alpha-L-arabinopyranosyl)oxy]-23-hydroxylup-20(29)-en-28-oic acid 28-O-alpha-L-rhamnopyranosyl-(1->4)-O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl ester

C53H86O21 (1058.5661306)


   

Araloside B

6-{[4,4,6a,6b,11,11,14b-heptamethyl-8a-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl]oxy}-3,4-bis({[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy})-5-hydroxyoxane-2-carboxylic acid

C52H82O22 (1058.5297472)


   

Ciwujianoside C3

Ciwujianoside C3

C53H86O21 (1058.5661306)


ciwujianoside C3 is a natural product found in Cussonia arborea, Meryta denhamii, and other organisms with data available.

   

C52H82O22

NCGC00381102-01_C52H82O22_

C52H82O22 (1058.5297472)


   

Matesaponin 2

3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl 10-[(5-hydroxy-4-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl)oxy]-1,2,6a,6b,9,9,12a-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-4a-carboxylate

C53H86O21 (1058.5661306)


   

Momordin IIe

6-{[4,4,6a,6b,11,11,14b-heptamethyl-8a-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl]oxy}-3-hydroxy-4,5-bis[(3,4,5-trihydroxyoxan-2-yl)oxy]oxane-2-carboxylic acid

C52H82O22 (1058.5297472)


   

Pulchinenoside E2

oleanolic acid 3-O-[O-beta-D-glucopyranosyl-(1->4)-O-beta-D-glucopyranosyl-(1->3)-O-alpha-L-rhamnopyranosyl-(1->2)-alpha-L-arabinopyranoside]

C53H86O21 (1058.5661306)


A triterpenoid saponin that is the tetrasaccharide derivative of oleanolic acid. Isolated from the roots of Pulsatilla chinensis, it exhibits antineoplastic activity.

   

Clethroidoside C

Clethroidoside C

C53H86O21 (1058.5661306)


A triterpenoid saponin that is (3beta)-3-hydroxy-13,28-epoxyoleanan-16-one attached to a tetrasaccharide residue at position 3 via a glycosidic linkage. Isolated from the aerial parts of Lysimachia clethroides, it exhibits antineoplastic activity.

   
   
   

PIP(20:1(11Z)/6 keto-PGF1alpha)

PIP(20:1(11Z)/6 keto-PGF1alpha)

C49H88O20P2 (1058.5343908)


   

PIP(6 keto-PGF1alpha/20:1(11Z))

PIP(6 keto-PGF1alpha/20:1(11Z))

C49H88O20P2 (1058.5343908)


   

PIP(22:2(13Z,16Z)/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

PIP(22:2(13Z,16Z)/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

C53H88O17P2 (1058.5496458)


   

PIP(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/22:2(13Z,16Z))

PIP(22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)/22:2(13Z,16Z))

C53H88O17P2 (1058.5496458)


   

PIP(22:2(13Z,16Z)/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

PIP(22:2(13Z,16Z)/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

C53H88O17P2 (1058.5496458)


   

PIP(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/22:2(13Z,16Z))

PIP(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/22:2(13Z,16Z))

C53H88O17P2 (1058.5496458)


   

PIP(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

PIP(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

C53H88O17P2 (1058.5496458)


   

PIP(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/22:2(13Z,16Z))

PIP(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/22:2(13Z,16Z))

C53H88O17P2 (1058.5496458)


   

PIP(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

PIP(22:2(13Z,16Z)/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

C53H88O17P2 (1058.5496458)


   

PIP(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/22:2(13Z,16Z))

PIP(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/22:2(13Z,16Z))

C53H88O17P2 (1058.5496458)


   

PIP(22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

PIP(22:2(13Z,16Z)/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

C53H88O17P2 (1058.5496458)


   

PIP(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/22:2(13Z,16Z))

PIP(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/22:2(13Z,16Z))

C53H88O17P2 (1058.5496458)


   

kinetensin (1-8)

kinetensin (1-8)

C50H74N16O10 (1058.5773543999999)


An 8 amino acid oligopeptide fragment of kinetensin lacking the C-terminal L-leucine residue.

   
   

(2s,3s,4s,5r,6s)-6-{[(3r,4ar,6ar,6bs,8s,8as,12ar,14ar,14bs)-8a-({[(2r,3r,4r,5r)-3-{[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-methyl-5-{[(2r,3s,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl]oxy}carbonyl)-8-hydroxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

(2s,3s,4s,5r,6s)-6-{[(3r,4ar,6ar,6bs,8s,8as,12ar,14ar,14bs)-8a-({[(2r,3r,4r,5r)-3-{[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-methyl-5-{[(2r,3s,4s,5s)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl]oxy}carbonyl)-8-hydroxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C52H82O22 (1058.5297472)


   

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl (4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-{[(2s,3s,4r,5r)-4,5-dihydroxy-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl (4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-{[(2s,3s,4r,5r)-4,5-dihydroxy-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C53H86O21 (1058.5661306)


   

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl (4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-{[(2s,3r,4s,5r)-4,5-dihydroxy-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl (4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-{[(2s,3r,4s,5r)-4,5-dihydroxy-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C53H86O21 (1058.5661306)


   

(5r,8s,11r,15s,18s,19s,22r)-15-(3-carbamimidamidopropyl)-3,6,9,13,16,20-hexahydroxy-8-[2-(4-hydroxyphenyl)ethyl]-18-[(1e,3e,5s,6s)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dien-1-yl]-22-(methoxycarbonyl)-1,5,19-trimethyl-2-methylidene-25-oxo-1,4,7,10,14,17,21-heptaazacyclopentacosa-3,6,9,13,16,20-hexaene-11-carboxylic acid

(5r,8s,11r,15s,18s,19s,22r)-15-(3-carbamimidamidopropyl)-3,6,9,13,16,20-hexahydroxy-8-[2-(4-hydroxyphenyl)ethyl]-18-[(1e,3e,5s,6s)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dien-1-yl]-22-(methoxycarbonyl)-1,5,19-trimethyl-2-methylidene-25-oxo-1,4,7,10,14,17,21-heptaazacyclopentacosa-3,6,9,13,16,20-hexaene-11-carboxylic acid

C53H74N10O13 (1058.5436554)


   

10-[(6-{[(3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl)oxy]methyl}-4,5-dihydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-2-hydroxy-4,5,9,9,13,20,20-heptamethyl-22-oxahexacyclo[19.2.1.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-16-en-23-one

10-[(6-{[(3-{[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl)oxy]methyl}-4,5-dihydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-2-hydroxy-4,5,9,9,13,20,20-heptamethyl-22-oxahexacyclo[19.2.1.0¹,¹⁸.0⁴,¹⁷.0⁵,¹⁴.0⁸,¹³]tetracos-16-en-23-one

C52H82O22 (1058.5297472)


   

(2s,3s,4s,5r,6r)-6-{[(3s,4ar,6ar,6bs,8r,8ar,12as,14ar,14br)-8a-({[(2s,3r,4s,5r)-3-{[(2s,3r,4s,5r,6s)-3,4-dihydroxy-6-methyl-5-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl]oxy}carbonyl)-8-hydroxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

(2s,3s,4s,5r,6r)-6-{[(3s,4ar,6ar,6bs,8r,8ar,12as,14ar,14br)-8a-({[(2s,3r,4s,5r)-3-{[(2s,3r,4s,5r,6s)-3,4-dihydroxy-6-methyl-5-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl]oxy}carbonyl)-8-hydroxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C52H82O22 (1058.5297472)


   

(1s,3ar,3bs,7s,9ar,9bs,10s,11s,11as)-11-(acetyloxy)-7-{[(2r,4s,5r,6r)-5-{[(2s,4s,5r,6r)-5-{[(2s,4r,5r,6r)-5-{[(2s,3r,4r,5r,6r)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-3a,3b-dihydroxy-1-[(1s)-1-hydroxyethyl]-9a,11a-dimethyl-1h,2h,3h,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-10-yl acetate

(1s,3ar,3bs,7s,9ar,9bs,10s,11s,11as)-11-(acetyloxy)-7-{[(2r,4s,5r,6r)-5-{[(2s,4s,5r,6r)-5-{[(2s,4r,5r,6r)-5-{[(2s,3r,4r,5r,6r)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-4-methoxy-6-methyloxan-2-yl]oxy}-3a,3b-dihydroxy-1-[(1s)-1-hydroxyethyl]-9a,11a-dimethyl-1h,2h,3h,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-10-yl acetate

C53H86O21 (1058.5661306)


   

(2s,3s,4s,5r,6r)-6-{[(3s,4ar,6ar,6bs,8r,8ar,12as,14ar,14br)-8a-({[(2r,3s,4r,5r)-3-{[(2s,3r,4s,5r,6s)-3,4-dihydroxy-6-methyl-5-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl]oxy}carbonyl)-8-hydroxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

(2s,3s,4s,5r,6r)-6-{[(3s,4ar,6ar,6bs,8r,8ar,12as,14ar,14br)-8a-({[(2r,3s,4r,5r)-3-{[(2s,3r,4s,5r,6s)-3,4-dihydroxy-6-methyl-5-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}oxan-2-yl]oxy}-4,5-dihydroxyoxan-2-yl]oxy}carbonyl)-8-hydroxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C52H82O22 (1058.5297472)


   

(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl (4as,6as,6br,8ar,10s,12ar,12br,14bs)-2,2,6a,6b,9,9,12a-heptamethyl-10-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

(2s,3r,4s,5s,6r)-6-({[(2r,3r,4r,5s,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}methyl)-3,4,5-trihydroxyoxan-2-yl (4as,6as,6br,8ar,10s,12ar,12br,14bs)-2,2,6a,6b,9,9,12a-heptamethyl-10-{[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxy}-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C53H86O21 (1058.5661306)


   

3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl 9-({4,5-dihydroxy-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylate

3,4,5-trihydroxy-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl 9-({4,5-dihydroxy-3-[(3,4,5-trihydroxy-6-methyloxan-2-yl)oxy]oxan-2-yl}oxy)-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)-hexadecahydrocyclopenta[a]chrysene-3a-carboxylate

C53H86O21 (1058.5661306)


   

6-{[8a-({[3-({3,4-dihydroxy-6-methyl-5-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl}oxy)-4,5-dihydroxyoxan-2-yl]oxy}carbonyl)-8-hydroxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

6-{[8a-({[3-({3,4-dihydroxy-6-methyl-5-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl}oxy)-4,5-dihydroxyoxan-2-yl]oxy}carbonyl)-8-hydroxy-4,4,6a,6b,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicen-3-yl]oxy}-3,4,5-trihydroxyoxane-2-carboxylic acid

C52H82O22 (1058.5297472)


   

10-({3-[(4,5-dihydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-5-hydroxy-6-(hydroxymethyl)-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl}oxy)-11-hydroxy-1,6a,6b,9,9,12a-hexamethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

10-({3-[(4,5-dihydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl)oxy]-5-hydroxy-6-(hydroxymethyl)-4-[(3,4,5-trihydroxyoxan-2-yl)oxy]oxan-2-yl}oxy)-11-hydroxy-1,6a,6b,9,9,12a-hexamethyl-2-methylidene-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylic acid

C52H82O22 (1058.5297472)


   

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl (4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-{[(2s,3r,4s,5s)-4,5-dihydroxy-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl (4as,6as,6br,8ar,10s,12ar,12br,14bs)-10-{[(2s,3r,4s,5s)-4,5-dihydroxy-3-{[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}oxan-2-yl]oxy}-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,7,8,8a,10,11,12,12b,13,14b-tetradecahydropicene-4a-carboxylate

C53H86O21 (1058.5661306)